🔗 Share this article

The Nobel Prize in Physiology or Medicine was granted for revolutionary discoveries that clarify how the body's defense network attacks harmful pathogens while sparing the body's own cells.

A trio of renowned scientists—Japan's Prof. Sakaguchi and US scientists Mary Brunkow and Dr. Ramsdell—received this accolade.

The work identified specialized "sentinels" within the defense system that eliminate malfunctioning immune cells that could harming the organism.

The findings are now paving the way for innovative treatments for autoimmune diseases and malignancies.

The laureates will share a monetary award worth 11 million SEK.

Crucial Discoveries

"The research has been essential for comprehending how the body's defenses operates and why we do not all develop serious self-attack conditions," stated the chair of the award panel.

The trio's research explain a core question: How does the defense system protect us from numerous infections while keeping our healthy cells intact?

The immune system employs immune cells that scan for signs of disease, including viruses and germs it has not met before.

These cells employ sensors—known as receptors—that are produced by chance in a vast number of combinations.

This gives the defense network the capacity to fight a wide array of threats, but the unpredictability of the process unavoidably produces white blood cells that may target the host.

Protectors of the Immune System

Researchers earlier knew that a portion of these harmful white blood cells were eliminated in the thymus—where white blood cells mature.

The latest award recognizes the identification of regulatory T-cells—known as the immune system's "peacekeepers"—which patrol the system to neutralize other defenders that attack the body's own tissues.

It is known that this mechanism malfunctions in autoimmune diseases such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

A Nobel panel added, "The discoveries have laid the foundation for a new field of research and accelerated the development of new treatments, for instance for cancer and autoimmune diseases."

In cancer, regulatory T-cells prevent the system from attacking the growth, so research are focused on reducing their quantity.

For self-attack disorders, experiments are testing boosting T-reg cells so the body is no longer being harmed. A similar method could also be effective in reducing the chances of organ transplant failure.

Pioneering Studies

Prof Shimon Sakaguchi, from Osaka University, conducted tests on mice that had their thymus removed, leading to self-attack conditions.

The researcher showed that introducing defense cells from healthy mice could stop the disease—implying there was a system for blocking immune cells from attacking the host.

Mary Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were investigating an inherited autoimmune disease in mice and humans that resulted in the discovery of a genetic factor critical for how T-regs operate.

"The pioneering work has uncovered how the body's defenses is kept in check by regulatory T cells, stopping it from accidentally targeting the body's own tissues," commented a prominent physiology specialist.

"The research is a striking example of how basic biological research can have broad implications for human health."